Kevin Coveney
2023
In 2023, Kevin Coveney earned a total compensation of $358.7K as Chief Financial Officer at Enveric Biosciences.
Compensation breakdown
| Salary | $308,989 |
|---|---|
| Stock Awards | $49,688 |
| Total | $358,677 |
Coveney received $309K in salary, accounting for 86% of the total pay in 2023.
Coveney also received $49.7K in stock awards.
Rankings
In 2023, Kevin Coveney's compensation ranked 2,365th out of 2,983 executives tracked by ExecPay. In other words, Coveney earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,365 out of 2,983 | 21st |
Division Manufacturing | 1,328 out of 1,637 | 19th |
Major group Chemicals And Allied Products | 779 out of 906 | 14th |
Industry group Drugs | 760 out of 869 | 13th |
Industry Pharmaceutical Preparations | 546 out of 627 | 13th |
Source: SEC filing on April 16, 2024.
Coveney's colleagues
We found three more compensation records of executives who worked with Kevin Coveney at Enveric Biosciences in 2023.